Factors Associated With Underutilization of Antiviral Therapy in Preventing Hepatitis B Virus‐Related Hepatocellular Carcinoma
Three-quarters of patients who developed HBV-related HCC had not received antiviral therapy before HCC diagnosis. These patients were characterised by a lower proportion of cirrhosis, infrequent clinical visits, fewer HBV evaluations, more advanced HCC stage, and poorer prognosis.
Authors
- Chih‐Wen Lin (ORCID: https://orcid.org/0000-0003-2344-5056)
- Cheng‐Hao Tseng (ORCID: https://orcid.org/0000-0003-4507-2414)
- Yao‐Chun Hsu (ORCID: https://orcid.org/0000-0001-8984-5103)
- Jia‐Ling Wu (ORCID: https://orcid.org/0000-0002-7785-9134)
- Mindie H. Nguyen (ORCID: https://orcid.org/0000-0002-6275-4989)
- Chih‐Lung Hung
- Ying‐Nan Tsai (ORCID: https://orcid.org/0000-0002-8759-5259)
- S. Tseng
Institutions
- E-Da Hospital (TW)
- Stanford Medicine (US)
- National Cheng Kung University (TW)
- Stanford University (US)
- I-Shou University (TW)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1111/apt.70224
- Citations
- 3
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.06
Funders
- Gilead Sciences
- E-Da Hospital